Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
TVTX - TOTAL EQUITY
Total Equity TVTX - Travere Therapeutics, Inc.
59.1 M
LAST VALUE
17.42%
2 YEAR CAGR
-23.21%
5 YEAR CAGR
13.62%
10 YEAR CAGR